Enabling Standardization and Scale-up in Treg and other Next Generation Cell Therapies
Wednesday May 6, 2025
12:00 – 1:00 PM IST
Liffey Hall 2, Level 1
Chair/Moderator:
Cheryl Cox , Ph.D
Operations Director of Cell Therapies & Gene Engineering Facility
Moffitt Cancer Center, Florida, USA
Speakers:
Barabara Ressler, Ph.D
VP of Manufacturing Process Sciences
RoslinCT, Boston, USA
Kate Fynes, Ph.D
Senior CMC Translation Consultant
Exmoor Pharma, Bristol, U.K.
Manel Juan MD, Ph.D (or lab member)
Centro de Díagnóstico Biomédico
University Hospital Barcelona, Spain
Natalia Trzonkowska, Ph.D
Professor, International Centre for Cancer Vaccine Science
University of Gdańsk, Gdańsk, Poland
Sophie Blondel, Ph.D
Founder and CEO, FoxBio
Paris, France